Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans
about
Ghrelin's second life: from appetite stimulator to glucose regulatorInterrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevanceThe role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetesGhrelin.The Impact of Gastric Atrophy on the Incidence of DiabetesAnti-obesity and anti-hyperglycemic effects of cinnamaldehyde via altered ghrelin secretion and functional impact on food intake and gastric emptyingMetabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans.Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery.The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects.The ghrelin axis in disease: potential therapeutic indications.Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans.Fasting and postprandial levels of ghrelin, leptin and insulin in lean, obese and anorexic subjects.Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R.Acute administration of unacylated ghrelin has no effect on Basal or stimulated insulin secretion in healthy humans.Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice.The gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart.Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat.Associations of ghrelin with eating behaviors, stress, metabolic factors, and telomere length among overweight and obese women: preliminary evidence of attenuated ghrelin effects in obesity?Clinical review: The human experience with ghrelin administration.Serum acylated ghrelin is negatively correlated with the insulin resistance in the CODING studyThe effects of sleeve gastrectomy on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor.Endocrine determinants of changes in insulin sensitivity and insulin secretion during a weight cycle in healthy menGhrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet β-cells.Overview of exocrine pancreatic pathobiology.Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells.Twenty-four-hour profiles of acylated and total ghrelin: relationship with glucose levels and impact of time of day and sleep.Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.Peptides and their potential role in the treatment of diabetes and obesity.Development and validation of an UPLC-MS/MS assay for quantitative analysis of the ghrelin receptor inverse agonist PF-5190457 in human or rat plasma and rat brain.The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelinEffects of sleep restriction on glucose control and insulin secretion during diet-induced weight loss.Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats.Serum Concentrations of Ghrelin and Leptin according to Thyroid Hormone Condition, and Their Correlations with Insulin Resistance.Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humansSynthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction.Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk.
P2860
Q26828009-95568948-42C6-4641-8DA1-BCC78336C4F1Q26852874-AC186396-1FC3-4547-A985-6718CBFDA5D9Q28080912-63BD797C-8AAF-434F-B042-E1B090574953Q28081062-AAABABD6-1320-404C-9E83-6007F52BC875Q28357299-38848B03-AAFD-4229-A32E-3B7BE4559D15Q28504944-D3D08F86-6A60-4EA4-A621-2A9E621A7AE5Q30252857-6119D3D2-4689-4775-AD86-31382CBBDA3AQ30277979-4F4A4CF8-31A8-48AE-BF17-84572937A811Q30416543-65F9EEB2-7B36-4AF9-8972-94B0B1A0C8A3Q30426399-210D3F32-5391-4823-BB20-5054B1F6071BQ30426403-A737CEE6-754F-4AFC-AFC6-7EC6073435DBQ30500141-3F352FC5-718E-40F8-9B81-2188AF5FB056Q33636655-7E5E8B11-B804-46E3-A9EE-7210B7903362Q33681282-C34FE22A-9B9B-4AA3-87A9-15DF60D33893Q33789384-2DC55C24-EDC8-4A15-A42D-37F5DE432846Q33811125-B7FD3B0F-5633-47F6-8159-649007973D73Q33986863-87EA8412-76D8-4CDC-861C-A8EC6F6B9A43Q34162234-CCA3B335-3C59-420D-B9F0-F235188C87CDQ34219154-1CF44D9A-61F9-44B4-8D11-499B7F1E8D4AQ34335494-FFFE5F12-ED34-407A-AACF-5E446AFC4C80Q34429728-99CAC33C-5F9F-45F3-9271-F40AE58DFB5BQ34468600-A6960B0C-17F8-4C17-8219-3EF945762E71Q34746192-9FED513D-D7D6-4B9D-B109-79FC159B1DC4Q35130125-2531CD03-0998-4DD5-8022-9130220FBD5BQ35180070-612C3FB0-D2DB-457F-895F-E8885E6A22C6Q35180122-AA8D7A88-6F42-4ACB-86BE-B788BC0E98A3Q35193163-2BA71D7C-FB88-4CD5-A8FE-619016A6D25BQ35504413-C70A4A74-B8B1-407D-A949-BAD7700D4425Q35704336-2F00D01A-FC72-44BA-97AF-5B66EE61AAD0Q35760298-598B8E32-7DBB-45CD-8A3E-DCC026969B38Q35842204-708D7715-28ED-46E5-A3E8-10D4E768242CQ36060564-DEE76F9D-8A1E-47D9-8624-24308D0607CAQ36063018-B4BEB8E3-56E3-45E7-B00A-F1A3F4641883Q36113941-7D79CDE5-4E9E-4BCC-B429-668E56DE45C7Q36127595-A6952567-28DD-46A5-9332-9147E712F93FQ36201527-F3BAC3C6-BBA1-4434-9FFF-798735812091Q36263619-B1FC3855-E552-4057-B045-832B0DE9D2A0Q36327109-F0BF5FC4-FCCE-4FE4-B7A5-8CDF8627FF24Q36568896-FB3252C0-583A-4312-BFBC-9C3CEDFF3671Q36572150-D362C172-2E8B-4ADC-A85C-DE297D6F7DCC
P2860
Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@ast
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@en
type
label
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@ast
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@en
prefLabel
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@ast
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@en
P2093
P2860
P356
P1433
P1476
Ghrelin suppresses glucose-sti ...... se tolerance in healthy humans
@en
P2093
David D'Alessio
David E Cummings
Harold W Davis
Jenny Tong
Ronald L Prigeon
P2860
P304
P356
10.2337/DB10-0504
P407
P577
2010-06-28T00:00:00Z